Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
| Conditions: | Non-Small Cell Lung Cancer and Pleural Mesothelioma |
| Start Date: | January 1, 2006 |
| Phase: | Phase I|Phase II |
| Status: | Suspended |
| NCT ID: | NCT00281125 |
| Study Type: | Interventional |
| Intervention: | Drug: PTK787 and Pemetrexed with or without Cisplatin |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Nevada Cancer Institute |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other |
| First Received: | January 6, 2006 |
| End Date: | September 1, 2006 |
| Last Updated: | September 6, 2006 |
| Last Verified: | September 1, 2006 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
